Globus Expects Durable Above Market Growth Post M&A Phase
The company grew 5% on a pro forma basis in 2025 as it transitions from an M&A cycle to a product development cycle. Feb 26, 2026
ATEC’s Clinical Distinction Driving Broad Adoption Trends
The company grew 25% in 2025 as the clinical distinction among its products drives surgeon adoption and utilization across its portfolio. Feb 26, 2026
SI-BONE Hits Milestones to Close Out 2025
The company grew over 20% in 2025, grew its surgeon user base by 22% and performed nearly 22,000 procedures. Feb 25, 2026
Medtronic Expects Acceleration from Stealth Axis Launch
The company grew in the mid-single-digits in FY 3Q26 on the strength of core spine pull-through from its enabling technology offerings. Feb 19, 2026
The State of Joint Replacement 2026
A look into emerging share opportunities for challengers, the battle for technology leadership and the impact of active portfolio management. Feb 19, 2026
Zimmer Biomet Embarks on US Channel Transformation
The company grew in the double digits for the fourth quarter of 2025, but tempered expectations for 2026 due to its U.S. channel overhaul. Feb 13, 2026
What to Expect from Top Players in 2026
We look at what we’re expecting from the top eight companies in orthopedics during 2026. Feb 12, 2026
The Last 10 Years of Orthopedic M&A Transactions
Our chart of the month looks at how orthopedic M&A trends for product segments has changed since 2020 and what the future might hold. Feb 10, 2026
Orthopedic Companies Report Results from Fourth Quarter 2025
Stay up to date on the orthopedic market's 4Q performance in 2025 as we update this post with company sales data and industry developments. Feb 05, 2026
Stryker’s High-Growth Offense Surges to End 2025
The company grew in the high single digits on a pro forma basis on the strength of Mako, shoulders and sports medicine. Feb 02, 2026
